Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.93 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.80.
Market Cap
8.93T
Revenue
4.59T
Profits
199.3B
PE Ratio
44.80
Profit Margin
4.34%
Dividend Yield
0.40%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.07T | -2.48% | 3,719,151 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 611.36B | -1.76% | 7,832,391 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 444.60B | -1.05% | 6,999,719 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 377.45B | -1.00% | 5,779,804 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 317.37B | -0.68% | 11,833,589 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 290.16B | -0.70% | 2,598,687 | 60.44B |
| 7 | NVS | Novartis AG | 286.77B | -0.55% | 1,755,154 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 212.92B | -0.83% | 8,579,350 | 50.57B |
| 9 | AMGN | Amgen Inc. | 195.44B | 0.44% | 2,246,899 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 186.32B | -1.00% | 2,423,734 | 45.20B |
| 11 | ABT | Abbott Laboratories | 158.05B | -2.12% | 10,021,148 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 156.86B | 0.01% | 7,409,543 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 140.84B | -2.04% | 2,585,416 | 10.58B |
| 14 | PFE | Pfizer Inc. | 137.24B | -1.19% | 60,046,016 | 63.32B |
| 15 | DHR | Danaher Corporation | 134.82B | -1.19% | 3,471,370 | 24.78B |
| 16 | CVS | CVS Health Corporation | 131.99B | -0.13% | 5,623,298 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.07B | -0.58% | 1,738,305 | 12.22B |
| 18 | SYK | Stryker Corporation | 120.70B | -4.49% | 2,955,952 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.66B | -1.61% | 11,346,264 | 48.48B |
| 20 | GSK | GSK plc | 104.73B | -0.74% | 4,011,092 | 43.29B |
| 21 | SNY | Sanofi | 102.95B | -1.77% | 2,882,934 | 54.60B |
| 22 | MDT | Medtronic plc | 100.14B | -3.34% | 9,876,665 | 36.36B |
| 23 | MCK | McKesson Corporation | 88.46B | 1.08% | 1,688,425 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.49B | -0.62% | 1,238,993 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 83.98B | -0.34% | 1,841,783 | 200.42B |
| 26 | CI | The Cigna Group | 72.93B | -1.10% | 1,458,659 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 63.44B | -1.31% | 818,726 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 63.44B | -1.84% | 42,982,874 | 20.61B |
| 29 | ARGX | argenx SE | 57.65B | 1.68% | 359,263 | 4.74B |
| 30 | CAH | Cardinal Health, Inc. | 55.64B | 0.57% | 1,666,875 | 250.74B |
| 31 | COR | Cencora, Inc. | 55.06B | 0.47% | 1,967,608 | 328.68B |
| 32 | EW | Edwards Lifesciences Corporation | 52.09B | -0.79% | 3,627,025 | 6.30B |
| 33 | MDLN | Medline Inc. | 51.81B | -0.43% | 17,690,587 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.10B | 0.31% | 2,948,737 | 28.34B |
| 35 | HUM | Humana Inc. | 47.69B | 2.14% | 1,548,469 | 137.20B |
| 36 | BDX | Becton, Dickinson and Company | 41.70B | -2.49% | 2,109,078 | 22.23B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 41.53B | -1.77% | 763,423 | 4.45B |
| 38 | HLN | Haleon plc | 40.67B | - | 7,512,869 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.19B | 2.56% | 1,410,239 | 4.29B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.82B | -2.77% | 4,000,561 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 39.45B | 1.71% | 5,396,027 | 17.35B |
| 42 | NTRA | Natera, Inc. | 38.88B | -0.32% | 1,371,547 | 2.50B |
| 43 | A | Agilent Technologies, Inc. | 37.52B | 0.19% | 2,023,313 | 7.23B |
| 44 | WAT | Waters Corporation | 36.82B | 1.67% | 1,480,045 | 3.77B |
| 45 | ALC | Alcon Inc. | 32.96B | -0.75% | 1,973,150 | 10.63B |
| 46 | RPRX | Royalty Pharma plc | 32.29B | -1.79% | 2,572,420 | 2.44B |
| 47 | IQV | IQVIA Holdings Inc. | 32.25B | -0.03% | 1,357,504 | 16.63B |
| 48 | BIIB | Biogen Inc. | 31.90B | -0.26% | 1,091,318 | 9.94B |
| 49 | CNC | Centene Corporation | 31.70B | -0.54% | 4,597,976 | 178.33B |
| 50 | ONC | BeOne Medicines AG | 31.68B | -1.73% | 325,154 | 5.70B |
| 51 | ZTS | Zoetis Inc. | 30.13B | -1.90% | 8,321,714 | 9.53B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.12B | -1.60% | 6,595,179 | 20.98B |
| 53 | VEEV | Veeva Systems Inc. | 28.83B | 0.71% | 2,638,718 | 3.32B |
| 54 | RMD | ResMed Inc. | 28.14B | -1.79% | 1,503,606 | 5.54B |
| 55 | MRNA | Moderna, Inc. | 27.79B | 0.47% | 11,805,911 | 2.23B |
| 56 | ILMN | Illumina, Inc. | 26.60B | -2.91% | 1,754,660 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 25.99B | -3.76% | 4,300,348 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 25.84B | -0.07% | 1,091,799 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 25.82B | 1.48% | 235,029 | 4.09B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.45B | 1.90% | 6,160,113 | 8.26M |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.36B | 1.22% | 957,006 | 3.22B |
| 62 | BNTX | BioNTech SE | 23.53B | -1.28% | 561,328 | 3.23B |
| 63 | DGX | Quest Diagnostics Incorporated | 23.46B | -0.32% | 847,823 | 11.28B |
| 64 | INSM | Insmed Incorporated | 23.11B | 1.79% | 3,358,226 | 819.56M |
| 65 | UTHR | United Therapeutics Corporation | 23.00B | -0.57% | 551,070 | 3.17B |
| 66 | LH | Labcorp Holdings Inc. | 22.96B | 0.15% | 815,565 | 14.14B |
| 67 | INCY | Incyte Corporation | 22.65B | -1.13% | 1,830,643 | 5.36B |
| 68 | STE | STERIS plc | 20.52B | -1.25% | 832,697 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 19.89B | -2.41% | 3,380,920 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.49B | -2.16% | 10,545,141 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.95B | -0.86% | 1,075,808 | 3.10B |
| 72 | GMAB | Genmab A/S | 16.84B | 5.57% | 2,573,386 | 3.90B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 16.66B | -5.64% | 4,142,007 | 8.41B |
| 74 | ASND | Ascendis Pharma A/S | 16.57B | 1.15% | 630,494 | 998.25M |
| 75 | THC | Tenet Healthcare Corporation | 16.11B | -0.05% | 1,240,701 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.12B | -0.96% | 335,552 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.12B | 1.37% | 942,428 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 14.59B | 3.43% | 3,393,106 | 579.96M |
| 79 | BTSG | BrightSpring Health Services, Inc. | 14.53B | 1.10% | 3,199,579 | 13.65B |
| 80 | DVA | DaVita Inc. | 14.28B | 1.27% | 804,777 | 13.84B |
| 81 | COO | The Cooper Companies, Inc. | 13.99B | 0.45% | 3,907,597 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.68B | 0.24% | 2,599,391 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.36B | -1.39% | 1,311,658 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 13.31B | 0.42% | 1,067,775 | 8.27B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 13.10B | -1.74% | 2,039,214 | 1.06B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.60B | 1.51% | 1,195,929 | 708.24M |
| 87 | PEN | Penumbra, Inc. | 12.42B | 0.09% | 352,437 | 1.45B |
| 88 | RVTY | Revvity, Inc. | 12.41B | 0.04% | 2,512,646 | 2.90B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 1.83% | 393,458 | 1.13B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.29B | -0.53% | 3,475,783 | 4.89B |
| 91 | SNN | Smith & Nephew plc | 12.28B | -4.85% | 3,804,032 | 6.16B |
| 92 | FMS | Fresenius Medical Care AG | 12.15B | -0.40% | 694,040 | 22.32B |
| 93 | ALGN | Align Technology, Inc. | 12.08B | -2.75% | 1,372,496 | 4.10B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.95B | -2.49% | 3,387,385 | 3.58B |
| 95 | MOH | Molina Healthcare, Inc. | 11.91B | -0.37% | 1,107,526 | 43.10B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.57B | -2.37% | 2,403,843 | 105.82M |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.48B | 1.25% | 2,715,673 | 622.01M |
| 98 | SMMT | Summit Therapeutics Inc. | 11.31B | 1.75% | 5,320,494 | - |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.15B | -0.78% | 1,707,022 | 3.24B |
| 100 | BAX | Baxter International Inc. | 11.01B | -3.18% | 6,891,752 | 11.32B |
| 101 | TECH | Bio-Techne Corporation | 11.01B | -0.35% | 15,865,133 | 1.21B |
| 102 | KRYS | Krystal Biotech, Inc. | 10.96B | -1.71% | 309,068 | 417.30M |
| 103 | CRL | Charles River Laboratories International, Inc. | 10.92B | 0.54% | 1,061,317 | 4.03B |
| 104 | GMED | Globus Medical, Inc. | 10.73B | -5.87% | 2,418,465 | 3.10B |
| 105 | PODD | Insulet Corporation | 10.55B | -3.48% | 1,062,963 | 2.90B |
| 106 | ABVX | ABIVAX Société Anonyme | 10.52B | 38.60% | 8,956,416 | 5.67M |
| 107 | TEM | Tempus AI, Inc. | 10.40B | -0.65% | 4,807,471 | 1.36B |
| 108 | EHC | Encompass Health Corporation | 10.03B | 0.18% | 655,832 | 6.07B |
| 109 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.09% | 5,436,413 | - |
| 110 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 1,653,970 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.51B | -0.91% | 1,266,997 | 13.38B |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.43B | 4.89% | 1,134,754 | 51.48M |
| 113 | CORT | Corcept Therapeutics Incorporated | 9.33B | -1.07% | 738,637 | 769.10M |
| 114 | PRAX | Praxis Precision Medicines, Inc. | 9.33B | -4.50% | 740,081 | 7.46M |
| 115 | ENSG | The Ensign Group, Inc. | 9.29B | 1.38% | 860,413 | 5.27B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 9.28B | 1.41% | 1,833,885 | 1.51B |
| 117 | IBRX | ImmunityBio, Inc. | 9.17B | -0.17% | 9,299,169 | 140.98M |
| 118 | BRKR | Bruker Corporation | 9.09B | 0.79% | 2,006,949 | 3.46B |
| 119 | UHS | Universal Health Services, Inc. | 9.00B | 1.14% | 936,910 | 17.76B |
| 120 | ALKS | Alkermes plc | 8.73B | -0.26% | 2,958,381 | 1.56B |
| 121 | OSCR | Oscar Health, Inc. | 8.59B | -3.16% | 6,819,166 | 13.30B |
| 122 | PCVX | Vaxcyte, Inc. | 8.39B | 0.71% | 2,476,019 | - |
| 123 | GKOS | Glaukos Corporation | 8.20B | -1.71% | 1,086,135 | 551.35M |
| 124 | QGEN | Qiagen N.V. | 8.09B | -1.73% | 2,480,701 | 2.10B |
| 125 | HIMS | Hims & Hers Health, Inc. | 8.02B | 3.83% | 13,416,817 | 2.37B |
| 126 | ATR | AptarGroup, Inc. | 7.99B | -0.07% | 329,270 | 3.87B |
| 127 | IMVT | Immunovant, Inc. | 7.91B | 0.05% | 1,411,485 | - |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 7.88B | 0.78% | 560,872 | 74.06M |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 7.86B | -0.57% | 237,364 | 2.59B |
| 130 | TGTX | TG Therapeutics, Inc. | 7.79B | -1.40% | 2,576,998 | 700.35M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.71B | -1.53% | 1,451,591 | - |
| 132 | RGEN | Repligen Corporation | 7.70B | -0.41% | 1,106,310 | 763.34M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.61B | 0.90% | 982,228 | 217.17M |
| 134 | HQY | HealthEquity, Inc. | 7.55B | 2.86% | 930,861 | 1.34B |
| 135 | LNTH | Lantheus Holdings, Inc. | 7.22B | 1.24% | 913,562 | 1.55B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.14B | -4.82% | 986,845 | 569.61M |
| 137 | LQDA | Liquidia Corporation | 7.09B | 6.14% | 1,703,022 | 288.07M |
| 138 | PTCT | PTC Therapeutics, Inc. | 6.77B | - | 2,375,631 | 827.11M |
| 139 | AVTR | Avantor, Inc. | 6.76B | -1.30% | 6,502,691 | 6.55B |
| 140 | PACS | PACS Group, Inc. | 6.75B | 6.76% | 1,451,246 | 5.43B |
| 141 | COGT | Cogent Biosciences, Inc. | 6.61B | -0.10% | 5,628,805 | - |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.59B | 0.07% | 1,403,406 | - |
| 143 | HNGE | Hinge Health, Inc. | 6.42B | 1.87% | 1,806,894 | 646.34M |
| 144 | TWST | Twist Bioscience Corporation | 6.41B | 4.60% | 1,989,292 | 409.48M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | 0.65% | 879,068 | 274.48M |
| 146 | CGON | CG Oncology, Inc. | 6.27B | -3.63% | 1,405,170 | 5.07M |
| 147 | DFTX | Definium Therapeutics, Inc. | 6.24B | 1.05% | 4,322,337 | - |
| 148 | GRFS | Grifols, S.A. | 6.18B | -3.41% | 1,017,808 | 8.58B |
| 149 | CHE | Chemed Corporation | 6.16B | 1.27% | 201,309 | 2.54B |
| 150 | BLTE | Belite Bio, Inc | 6.06B | -0.43% | 217,540 | - |
| 151 | BLCO | Bausch + Lomb Corporation | 5.90B | -0.42% | 423,102 | 5.21B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.38% | 1,251,693 | 7.50M |
| 153 | ORKA | Oruka Therapeutics, Inc. | 5.74B | 2.90% | 1,755,594 | - |
| 154 | ERAS | Erasca, Inc. | 5.70B | 0.16% | 5,407,383 | - |
| 155 | TFX | Teleflex Incorporated | 5.61B | -0.57% | 355,563 | 2.13B |
| 156 | LEGN | Legend Biotech Corporation | 5.59B | -1.74% | 1,020,520 | 1.14B |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.52B | 0.12% | 2,257,979 | 3.05B |
| 158 | BLLN | BillionToOne, Inc. | 5.52B | -0.35% | 532,117 | 354.54M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.33B | 1.88% | 1,365,342 | 1.34M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.28B | -2.56% | 2,431,478 | 536.20M |
| 161 | CRSP | CRISPR Therapeutics AG | 5.26B | -3.21% | 1,187,814 | 4.10M |
| 162 | MANE | Veradermics, Incorporated | 5.14B | -0.52% | 613,808 | - |
| 163 | CELC | Celcuity Inc. | 5.10B | 2.05% | 1,088,196 | - |
| 164 | SHC | Sotera Health Company | 5.06B | 1.31% | 2,012,020 | 1.19B |
| 165 | CAI | Caris Life Sciences, Inc. | 5.04B | -2.73% | 3,758,155 | 907.29M |
| 166 | INDV | Indivior Pharmaceuticals, Inc. | 5.00B | -0.56% | 1,559,365 | 1.29B |
| 167 | STVN | Stevanato Group S.p.A. | 4.93B | 4.09% | 323,991 | 1.39B |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.92B | 2.36% | 3,659,379 | 4.26B |
| 169 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.92B | 2.47% | 1,307,638 | 754.05M |
| 170 | TXG | 10x Genomics, Inc. | 4.87B | 3.20% | 2,809,005 | 638.78M |
| 171 | RDNT | RadNet, Inc. | 4.85B | 4.03% | 810,536 | 2.14B |
| 172 | VCYT | Veracyte, Inc. | 4.69B | -2.43% | 1,324,124 | 541.74M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.53B | -1.34% | 3,106,853 | - |
| 174 | TNGX | Tango Therapeutics, Inc. | 4.52B | -3.99% | 4,760,941 | 56.99M |
| 175 | LIVN | LivaNova PLC | 4.52B | -1.00% | 664,292 | 1.43B |
| 176 | EWTX | Edgewise Therapeutics, Inc. | 4.37B | -0.71% | 968,012 | - |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.33B | 0.40% | 1,721,168 | 1.10B |
| 178 | NVST | Envista Holdings Corporation | 4.29B | -2.48% | 3,174,994 | 2.81B |
| 179 | MMED | MiniMed Group, Inc. | 4.20B | 0.47% | 847,110 | 3.10B |
| 180 | LFST | LifeStance Health Group, Inc. | 4.15B | 3.58% | 3,825,112 | 1.49B |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.14B | -1.07% | 491,791 | 1.54B |
| 182 | DNLI | Denali Therapeutics Inc. | 4.08B | -0.66% | 1,971,700 | - |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.08B | -5.22% | 5,799,103 | 10.68M |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 3.96B | 0.06% | 1,077,232 | 22.57M |
| 185 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | 1.30% | 748,918 | 18.07M |
| 186 | WAY | Waystar Holding Corp. | 3.94B | 2.75% | 2,818,007 | 1.16B |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.91B | 0.45% | 491,581 | 787.85M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.89B | 2.04% | 183,414 | 803.79M |
| 189 | RCUS | Arcus Biosciences, Inc. | 3.88B | -0.80% | 1,344,884 | 236.00M |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.10% | 4,766,637 | 596.96M |
| 191 | BKD | Brookdale Senior Living Inc. | 3.84B | 1.45% | 4,089,166 | 3.00B |
| 192 | GPCR | Structure Therapeutics Inc. | 3.81B | 3.83% | 1,194,491 | - |
| 193 | CON | Concentra Group Holdings Parent, Inc. | 3.81B | -0.07% | 1,241,015 | 2.23B |
| 194 | DOCS | Doximity, Inc. | 3.79B | 0.73% | 3,597,705 | 644.86M |
| 195 | WRBY | Warby Parker Inc. | 3.72B | 0.76% | 2,630,667 | 890.57M |
| 196 | ICUI | ICU Medical, Inc. | 3.68B | -0.48% | 171,024 | 2.16B |
| 197 | DYN | Dyne Therapeutics, Inc. | 3.67B | 4.47% | 2,510,125 | - |
| 198 | ALMS | Alumis Inc. | 3.59B | 3.68% | 2,340,313 | 8.40M |
| 199 | OGN | Organon & Co. | 3.56B | -0.07% | 1,833,968 | 6.16B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | 1.97% | 1,590,760 | 225.27M |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.54B | -0.20% | 1,987,139 | - |
| 202 | PBLS | Parabilis Medicines, Inc. | 3.49B | -6.24% | 580,136 | - |
| 203 | ADPT | Adaptive Biotechnologies Corporation | 3.42B | 0.23% | 3,799,376 | 295.41M |
| 204 | BEAM | Beam Therapeutics Inc. | 3.42B | -1.80% | 1,672,352 | 164.01M |
| 205 | HAE | Haemonetics Corporation | 3.41B | -0.16% | 562,613 | 1.33B |
| 206 | NHC | National HealthCare Corporation | 3.30B | 2.77% | 126,309 | 1.53B |
| 207 | OPCH | Option Care Health, Inc. | 3.29B | -1.64% | 2,300,772 | 5.67B |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -2.02% | 1,354,101 | 415.62M |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.28B | 8.83% | 6,939,332 | 670.00M |
| 210 | PRVA | Privia Health Group, Inc. | 3.24B | 0.70% | 883,213 | 2.25B |
| 211 | ITGR | Integer Holdings Corporation | 3.17B | 2.44% | 536,293 | 1.86B |
| 212 | QURE | uniQure N.V. | 3.17B | -2.81% | 2,048,618 | 18.09M |
| 213 | VERA | Vera Therapeutics, Inc. | 3.08B | -0.56% | 2,295,699 | - |
| 214 | RGC | Regencell Bioscience Holdings Limited | 3.02B | -1.62% | 447,669 | - |
| 215 | GRAL | GRAIL, Inc. | 2.93B | -0.18% | 374,430 | 156.12M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.92B | -0.61% | 2,473,017 | 865.00K |
| 217 | KLRA | Kailera Therapeutics, Inc. | 2.85B | 1.66% | 858,379 | - |
| 218 | IRON | Disc Medicine, Inc. | 2.79B | -1.83% | 729,507 | - |
| 219 | CLOV | Clover Health Investments, Corp. | 2.76B | -1.32% | 5,570,608 | 2.21B |
| 220 | SLS | SELLAS Life Sciences Group, Inc. | 2.75B | -4.47% | 21,628,763 | - |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.72B | 6.64% | 3,521,433 | 3.37B |
| 222 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 2.74% | 1,447,971 | 535.08M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.70B | -0.62% | 1,146,256 | 776.83M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | 3.54% | 783,167 | 1.46B |
| 225 | TRVI | Trevi Therapeutics, Inc. | 2.65B | 0.11% | 3,102,713 | - |
| 226 | MBX | MBX Biosciences, Inc. | 2.63B | 2.51% | 1,072,391 | - |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.54B | 4.71% | 7,719,542 | 885.72M |
| 228 | HTFL | HeartFlow, Inc. | 2.53B | -15.81% | 4,819,189 | 191.42M |
| 229 | ESTA | Establishment Labs Holdings Inc. | 2.53B | -1.84% | 616,390 | 229.58M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.51B | 1.72% | 2,156,036 | 71.78M |
| 231 | AXGN | Axogen, Inc. | 2.46B | 3.29% | 1,228,769 | 238.11M |
| 232 | KOD | Kodiak Sciences Inc. | 2.43B | 3.23% | 1,549,652 | - |
| 233 | PHVS | Pharvaris N.V. | 2.42B | -0.37% | 1,030,953 | - |
| 234 | IMNM | Immunome, Inc. | 2.40B | 0.71% | 1,513,535 | 4.02M |
| 235 | ABCL | AbCellera Biologics Inc. | 2.40B | -3.33% | 7,786,834 | 79.21M |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 0.37% | 2,030,353 | - |
| 237 | NTLA | Intellia Therapeutics, Inc. | 2.36B | 1.87% | 3,801,554 | 66.09M |
| 238 | NKTR | Nektar Therapeutics | 2.36B | 6.76% | 1,845,373 | 55.63M |
| 239 | ASTH | Astrana Health, Inc. | 2.30B | 3.06% | 1,274,108 | 3.53B |
| 240 | TMDX | TransMedics Group, Inc. | 2.30B | -1.29% | 1,419,742 | 635.89M |
| 241 | VCEL | Vericel Corporation | 2.27B | -1.29% | 743,264 | 292.09M |
| 242 | PGNY | Progyny, Inc. | 2.26B | -0.10% | 1,259,886 | 1.29B |
| 243 | BHVN | Biohaven Ltd. | 2.24B | -0.47% | 3,174,711 | - |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | -1.58% | 726,185 | 1.09B |
| 245 | AGIO | Agios Pharmaceuticals, Inc. | 2.21B | -2.44% | 987,908 | 66.05M |
| 246 | BFLY | Butterfly Network, Inc. | 2.20B | -5.50% | 7,610,829 | 102.92M |
| 247 | LMAT | LeMaitre Vascular, Inc. | 2.19B | -0.04% | 326,634 | 256.28M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.19B | -1.30% | 463,588 | - |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | 1.07% | 2,032,416 | 298.30M |
| 250 | TSHA | Taysha Gene Therapies, Inc. | 2.18B | 1.19% | 6,663,117 | 7.47M |
| 251 | SGRY | Surgery Partners, Inc. | 2.18B | 1.45% | 1,234,592 | 3.34B |
| 252 | GENB | Generate Biomedicines, Inc. | 2.16B | -0.24% | 1,333,506 | 30.30M |
| 253 | OCUL | Ocular Therapeutix, Inc. | 2.15B | -0.81% | 2,450,039 | 52.04M |
| 254 | ZLAB | Zai Lab Limited | 2.13B | 3.20% | 754,802 | 453.28M |
| 255 | KARD | Kardigan, Inc. | 2.13B | -7.92% | 808,453 | - |
| 256 | XRAY | DENTSPLY SIRONA Inc. | 2.13B | -1.94% | 4,629,861 | 3.68B |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.11B | 3.03% | 1,198,743 | 899.11M |
| 258 | UFPT | UFP Technologies, Inc. | 2.05B | 0.31% | 155,436 | 608.85M |
| 259 | SEM | Select Medical Holdings Corporation | 2.05B | -0.12% | 27,839,100 | 5.52B |
| 260 | GLUE | Monte Rosa Therapeutics, Inc. | 2.04B | 1.26% | 2,334,887 | 42.95M |
| 261 | WGS | GeneDx Holdings Corp. | 2.04B | -0.68% | 552,159 | 442.68M |
| 262 | STOK | Stoke Therapeutics, Inc. | 2.04B | 1.02% | 3,369,172 | 32.08M |
| 263 | PGEN | Precigen, Inc. | 2.03B | -3.72% | 4,217,181 | 31.60M |
| 264 | MD | Pediatrix Medical Group, Inc. | 2.03B | 2.59% | 704,043 | 1.93B |
| 265 | VRDN | Viridian Therapeutics, Inc. | 2.03B | -2.24% | 3,455,472 | 70.92M |
| 266 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.00B | -3.96% | 2,879,572 | -665.00K |
| 267 | RAPP | Rapport Therapeutics, Inc. | 1.99B | 3.17% | 556,050 | 20.00M |
| 268 | SION | Sionna Therapeutics, Inc. | 1.99B | 2.37% | 671,354 | - |
| 269 | NUVB | Nuvation Bio Inc. | 1.98B | 1.25% | 14,697,252 | 143.05M |
| 270 | LKFT | Lakefront Biotherapeutics NV | 1.97B | 1.04% | 166,176 | 1.20B |
| 271 | ANAB | AnaptysBio, Inc. | 1.96B | 2.32% | 706,090 | 232.39M |
| 272 | ABSI | Absci Corporation | 1.96B | 2.11% | 5,820,136 | 1.84M |
| 273 | NEOG | Neogen Corporation | 1.96B | -1.21% | 2,328,641 | 870.56M |
| 274 | BCAX | Bicara Therapeutics Inc. | 1.95B | 1.19% | 1,222,002 | - |
| 275 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | -0.54% | 23,159,953 | 66.41M |
| 276 | ATAI | AtaiBeckley Inc. | 1.94B | -1.68% | 8,291,312 | 3.49M |
| 277 | ADMA | ADMA Biologics, Inc. | 1.94B | - | 2,781,972 | 509.86M |
| 278 | SNDX | Syndax Pharmaceuticals, Inc. | 1.94B | 0.37% | 2,474,221 | 217.17M |
| 279 | PLSE | Pulse Biosciences, Inc. | 1.92B | -5.16% | 291,445 | 751.00K |
| 280 | CMPS | COMPASS Pathways plc | 1.91B | -6.10% | 3,467,572 | - |
| 281 | ZYME | Zymeworks Inc. | 1.91B | 8.46% | 1,077,728 | 81.26M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.90B | 2.85% | 1,060,073 | 367.34M |
| 283 | NEO | NeoGenomics, Inc. | 1.90B | 2.39% | 3,595,296 | 745.97M |
| 284 | TYRA | Tyra Biosciences, Inc. | 1.90B | -0.53% | 826,062 | - |
| 285 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | 5.58% | 4,213,964 | 2.18B |
| 286 | TRLV | Trulieve Cannabis Corp. | 1.89B | 6.39% | 1,512,654 | 1.17B |
| 287 | OMCL | Omnicell, Inc. | 1.89B | 1.47% | 547,935 | 1.23B |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.88B | -2.45% | 378,263 | 87.16M |
| 289 | AVAH | Aveanna Healthcare Holdings Inc. | 1.87B | -1.04% | 1,641,934 | 2.52B |
| 290 | NBTX | Nanobiotix S.A. | 1.86B | 4.84% | 99,566 | 38.27M |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.86B | -1.19% | 10,252,161 | 285.61M |
| 292 | HCM | HUTCHMED (China) Limited | 1.85B | 0.47% | 106,811 | 548.51M |
| 293 | GHRS | GH Research PLC | 1.84B | -5.65% | 212,678 | - |
| 294 | BHC | Bausch Health Companies Inc. | 1.84B | 1.65% | 3,873,412 | 10.53B |
| 295 | ADUS | Addus HomeCare Corporation | 1.84B | 2.47% | 302,985 | 1.45B |
| 296 | URGN | UroGen Pharma Ltd. | 1.79B | 2.02% | 670,547 | 140.49M |
| 297 | AGL | agilon health, inc. | 1.79B | -6.92% | 477,919 | 5.82B |
| 298 | AKTS | Aktis Oncology, Inc. | 1.78B | 7.04% | 1,211,796 | 8.28M |
| 299 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | -1.59% | 238,724 | 923.71M |
| 300 | NVCR | NovoCure Limited | 1.75B | -2.13% | 1,412,323 | 674.41M |
| 301 | MESO | Mesoblast Limited | 1.75B | -0.59% | 114,341 | 65.38M |
| 302 | VIR | Vir Biotechnology, Inc. | 1.72B | -1.83% | 1,724,853 | 65.50M |
| 303 | COAG | Hemab Therapeutics Holdings, Inc. | 1.72B | 0.03% | 321,549 | - |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.69B | 0.24% | 610,730 | 1.85B |
| 305 | INVA | Innoviva, Inc. | 1.68B | -1.86% | 630,113 | 420.69M |
| 306 | MAZE | Maze Therapeutics, Inc. | 1.65B | 2.90% | 653,185 | 20.00M |
| 307 | FTRE | Fortrea Holdings Inc. | 1.65B | -0.68% | 1,080,943 | 2.71B |
| 308 | MPLT | MapLight Therapeutics, Inc. | 1.63B | 4.49% | 418,194 | - |
| 309 | AVBP | ArriVent BioPharma, Inc. | 1.62B | 1.08% | 643,802 | - |
| 310 | IMCR | Immunocore Holdings plc | 1.61B | 4.37% | 615,254 | 412.81M |
| 311 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | -2.35% | 3,633,704 | 204.73M |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.61B | -2.21% | 1,487,337 | - |
| 313 | INNV | InnovAge Holding Corp. | 1.61B | 2.07% | 948,796 | 949.17M |
| 314 | ZBIO | Zenas BioPharma, Inc. | 1.60B | -0.67% | 867,657 | 10.00M |
| 315 | DMRA | Damora Therapeutics, Inc. | 1.60B | 7.43% | 569,218 | - |
| 316 | SVRA | Savara Inc. | 1.56B | 2.16% | 2,144,017 | - |
| 317 | AAPG | Ascentage Pharma Group International | 1.56B | -1.75% | 458 | 82.08M |
| 318 | NVAX | Novavax, Inc. | 1.55B | 0.64% | 3,984,675 | 596.34M |
| 319 | HROW | Harrow, Inc. | 1.53B | 3.21% | 1,065,254 | 268.68M |
| 320 | TDOC | Teladoc Health, Inc. | 1.53B | -2.42% | 3,661,133 | 2.51B |
| 321 | SEPN | Septerna, Inc. | 1.51B | -3.63% | 747,614 | 72.26M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.49B | 0.36% | 328,666 | 83.72M |
| 323 | CDNA | CareDx, Inc. | 1.47B | -2.66% | 642,716 | 412.82M |
| 324 | AVLN | Avalyn Pharma Inc. | 1.46B | 6.19% | 540,848 | - |
| 325 | PRGO | Perrigo Company plc | 1.44B | 3.38% | 3,922,839 | 4.18B |
| 326 | STAA | STAAR Surgical Company | 1.43B | -2.18% | 647,124 | 290.38M |
| 327 | ATRC | AtriCure, Inc. | 1.42B | -2.51% | 1,198,971 | 552.16M |
| 328 | ARDT | Ardent Health, Inc. | 1.41B | -0.91% | 476,950 | 6.43B |
| 329 | PSNL | Personalis, Inc. | 1.40B | -2.55% | 4,099,363 | 64.52M |
| 330 | IART | Integra LifeSciences Holdings Corporation | 1.40B | -4.16% | 935,940 | 1.64B |
| 331 | CAPR | Capricor Therapeutics, Inc. | 1.39B | 1.18% | 1,858,849 | 11.13M |
| 332 | INBX | Inhibrx Biosciences, Inc. | 1.39B | -0.69% | 217,855 | 1.30M |
| 333 | AHCO | AdaptHealth Corp. | 1.39B | 2.06% | 1,570,855 | 3.29B |
| 334 | IMTX | Immatics N.V. | 1.38B | 5.96% | 753,500 | 43.00M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.38B | -0.21% | 1,248,563 | 101.66M |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.37B | 2.33% | 2,194,909 | 314.85M |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.33B | -8.95% | 4,094,009 | 787.08M |
| 338 | JBIO | Jade Biosciences, Inc. | 1.32B | 0.50% | 893,408 | - |
| 339 | MNKD | MannKind Corporation | 1.32B | 0.47% | 6,822,023 | 360.78M |
| 340 | OMDA | Omada Health, Inc. | 1.31B | 1.29% | 853,679 | 283.30M |
| 341 | INSP | Inspire Medical Systems, Inc. | 1.29B | -0.71% | 650,066 | 915.25M |
| 342 | PRCT | PROCEPT BioRobotics Corporation | 1.29B | - | 1,302,620 | 322.02M |
| 343 | AHG | Akso Health Group | 1.28B | 2.76% | 4,249 | 14.84M |
| 344 | PAHC | Phibro Animal Health Corporation | 1.27B | -1.29% | 295,248 | 1.50B |
| 345 | PNTG | The Pennant Group, Inc. | 1.26B | 1.68% | 315,462 | 1.02B |
| 346 | ARDX | Ardelyx, Inc. | 1.26B | -2.49% | 7,361,391 | 427.68M |
| 347 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 3.18% | 1,499,757 | - |
| 348 | AMN | AMN Healthcare Services, Inc. | 1.26B | -0.03% | 828,736 | 3.42B |
| 349 | MGTX | MeiraGTx Holdings plc | 1.25B | 7.74% | 1,766,010 | 79.76M |
| 350 | ALVO | Alvotech | 1.25B | -0.81% | 853,797 | 562.04M |
| 351 | IRMD | IRADIMED CORPORATION | 1.22B | 1.49% | 109,602 | 86.28M |
| 352 | SDGR | Schrödinger, Inc. | 1.21B | -6.56% | 2,721,033 | 254.91M |
| 353 | EYPT | EyePoint, Inc. | 1.20B | 1.35% | 2,319,320 | 7.61M |
| 354 | QDEL | QuidelOrtho Corporation | 1.19B | -3.92% | 1,688,435 | 2.66B |
| 355 | XNCR | Xencor, Inc. | 1.19B | 3.21% | 1,500,262 | 97.36M |
| 356 | ENOV | Enovis Corporation | 1.19B | -5.99% | 2,373,297 | 2.28B |
| 357 | AZTA | Azenta, Inc. | 1.18B | 0.04% | 379,661 | 596.48M |
| 358 | NUTX | Nutex Health Inc. | 1.18B | 1.96% | 86,635 | 879.95M |
| 359 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | 0.61% | 357,579 | 796.33M |
| 360 | AVNS | Avanos Medical, Inc. | 1.17B | -0.20% | 309,995 | 715.90M |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.16B | -3.55% | 263,900 | - |
| 362 | DRTS | Alpha Tau Medical Ltd. | 1.13B | 12.12% | 2,240,771 | - |
| 363 | OPK | OPKO Health, Inc. | 1.13B | -0.66% | 2,328,609 | 581.12M |
| 364 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 6.59% | 1,665,494 | - |
| 365 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | -1.14% | 625,530 | - |
| 366 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.29% | 3,168,890 | 71.80M |
| 367 | OLMA | Olema Pharmaceuticals, Inc. | 1.09B | 2.54% | 2,468,738 | - |
| 368 | AORT | Artivion, Inc. | 1.09B | 0.36% | 913,631 | 458.69M |
| 369 | BIOA | BioAge Labs, Inc. | 1.09B | -1.76% | 805,367 | 10.32M |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | -1.74% | 661,542 | 1.03B |
| 371 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | -9.09% | 5,191,551 | 69.64M |
| 372 | SANA | Sana Biotechnology, Inc. | 1.05B | 1.16% | 2,349,885 | - |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.05B | -0.20% | 192,304 | 787.69M |
| 374 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | -4.67% | 1,145,880 | 1.03B |
| 375 | CRON | Cronos Group Inc. | 1.03B | -2.46% | 1,325,176 | 159.54M |
| 376 | CERT | Certara, Inc. | 1.02B | 2.99% | 5,107,999 | 419.75M |
| 377 | EVO | Evotec SE | 1.01B | - | 28,165 | 859.03M |
| 378 | PCRX | Pacira BioSciences, Inc. | 998.26M | 1.12% | 619,475 | 734.86M |
| 379 | VOR | Vor Biopharma Inc. | 997.56M | -1.02% | 1,378,399 | - |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 991.60M | -1.44% | 443,532 | 86.93M |
| 381 | CNMD | CONMED Corporation | 985.47M | -4.88% | 460,149 | 1.37B |
| 382 | SLDB | Solid Biosciences Inc. | 983.51M | 5.49% | 2,367,793 | - |
| 383 | GDRX | GoodRx Holdings, Inc. | 975.39M | 1.05% | 978,504 | 787.89M |
| 384 | KURA | Kura Oncology, Inc. | 973.85M | - | 1,529,261 | 71.64M |
| 385 | AVTX | Avalo Therapeutics, Inc. | 971.41M | -4.20% | 2,399,786 | 59.00K |
| 386 | PHAR | Pharming Group N.V. | 969.86M | 3.66% | 6,978 | 369.49M |
| 387 | AVR | Anteris Technologies Global Corp. | 958.82M | 0.72% | 1,746,376 | 1.85M |
| 388 | DBVT | DBV Technologies S.A. | 953.36M | 2.50% | 240,925 | 5.74M |
| 389 | ABUS | Arbutus Biopharma Corporation | 948.18M | 2.56% | 2,764,617 | 191.45M |
| 390 | JANX | Janux Therapeutics, Inc. | 936.72M | 0.20% | 1,223,555 | 13.73M |
| 391 | ANNX | Annexon, Inc. | 935.54M | 2.51% | 3,633,748 | - |
| 392 | LBRX | LB Pharmaceuticals Inc | 930.70M | -0.57% | 334,079 | - |
| 393 | REPL | Replimune Group, Inc. | 929.27M | -1.16% | 4,327,328 | - |
| 394 | INMD | InMode Ltd. | 926.30M | -0.81% | 834,822 | 374.64M |
| 395 | ANRO | Alto Neuroscience, Inc. | 926.13M | -5.99% | 424,108 | - |
| 396 | DSGN | Design Therapeutics, Inc. | 903.75M | 1.62% | 1,201,679 | - |
| 397 | ODTX | Odyssey Therapeutics, Inc. | 895.80M | -0.95% | 459,730 | 1.06M |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 889.35M | -2.61% | 400,007 | 720.53M |
| 399 | TBPH | Theravance Biopharma, Inc. | 876.40M | -0.35% | 2,030,625 | 109.78M |
| 400 | TALK | Talkspace, Inc. | 871.07M | - | 2,191,002 | 238.37M |
| 401 | IVA | Inventiva S.A. | 869.21M | 6.48% | 2,095,680 | 7.94M |
| 402 | PHAT | Phathom Pharmaceuticals, Inc. | 861.82M | -0.18% | 665,604 | 204.89M |
| 403 | ZVRA | Zevra Therapeutics, Inc. | 847.71M | 2.36% | 1,482,615 | 122.29M |
| 404 | OCS | Oculis Holding AG | 837.58M | 5.96% | 633,517 | 1.40M |
| 405 | GMRS | GMR Solutions Inc. | 835.02M | 5.03% | 1,210,016 | 5.83B |
| 406 | SSII | SS Innovations International, Inc. | 830.55M | 17.56% | 248,066 | 48.47M |
| 407 | GERN | Geron Corporation | 821.15M | -1.54% | 12,592,432 | 196.12M |
| 408 | CTMX | CytomX Therapeutics, Inc. | 816.39M | 0.27% | 5,925,882 | 35.54M |
| 409 | ESPR | Esperion Therapeutics, Inc. | 813.48M | 0.32% | 4,881,923 | 418.24M |
| 410 | HSTM | HealthStream, Inc. | 796.11M | 0.44% | 186,747 | 311.78M |
| 411 | SPRY | ARS Pharmaceuticals, Inc. | 795.42M | -6.43% | 1,327,070 | 98.99M |
| 412 | BVS | Bioventus Inc. | 788.57M | -3.48% | 728,939 | 576.30M |
| 413 | AURA | Aura Biosciences, Inc. | 783.13M | 3.20% | 1,260,782 | - |
| 414 | SLBT | SL Science Holding Limited | 774.18M | 40.88% | 953,879 | - |
| 415 | CADL | Candel Therapeutics, Inc. | 754.68M | -0.58% | 2,942,998 | - |
| 416 | SGP | SpyGlass Pharma, Inc. | 750.75M | 3.72% | 81,930 | - |
| 417 | CLYM | Climb Bio, Inc. | 747.82M | -2.25% | 1,566,283 | - |
| 418 | TENX | Tenax Therapeutics, Inc. | 743.39M | 7.78% | 1,330,632 | - |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 738.82M | 5.38% | 3,207,889 | 8.37M |
| 420 | CBLL | CeriBell, Inc. | 737.99M | -2.56% | 505,081 | 95.07M |
| 421 | IMMX | Immix Biopharma, Inc. | 733.97M | -1.72% | 2,392,836 | - |
| 422 | RLMD | Relmada Therapeutics, Inc. | 725.84M | -0.86% | 2,320,445 | - |
| 423 | RIGL | Rigel Pharmaceuticals, Inc. | 723.80M | 0.20% | 345,149 | 299.77M |
| 424 | SIBN | SI-BONE, Inc. | 723.78M | -3.41% | 1,638,029 | 206.22M |
| 425 | CSTL | Castle Biosciences, Inc. | 723.37M | -1.93% | 336,700 | 339.92M |
| 426 | ALLO | Allogene Therapeutics, Inc. | 717.92M | -6.31% | 17,982,571 | 22.00K |
| 427 | EIKN | Eikon Therapeutics, Inc. | 706.51M | 2.43% | 350,547 | - |
| 428 | DRUG | Bright Minds Biosciences Inc. | 704.76M | 1.47% | 259,516 | - |
| 429 | TRAX | First Tracks Biotherapeutics, Inc. | 702.03M | 18.28% | 883,206 | - |
| 430 | BBNX | Beta Bionics, Inc. | 698.28M | -7.82% | 931,657 | 110.24M |
| 431 | FDMT | 4D Molecular Therapeutics, Inc. | 695.27M | 3.26% | 2,796,276 | 88.24M |
| 432 | IRWD | Ironwood Pharmaceuticals, Inc. | 693.02M | -2.09% | 2,586,069 | 361.51M |
| 433 | OMER | Omeros Corporation | 688.29M | -4.04% | 1,944,775 | 9.89M |
| 434 | TCMD | Tactile Systems Technology, Inc. | 671.73M | -1.62% | 205,160 | 343.52M |
| 435 | ACHV | Achieve Life Sciences, Inc. | 670.36M | 4.82% | 2,461,696 | - |
| 436 | PRME | Prime Medicine, Inc. | 666.48M | -0.81% | 2,690,438 | 4.03M |
| 437 | TECX | Tectonic Therapeutic, Inc. | 648.63M | 3.88% | 193,601 | - |
| 438 | DNA | Ginkgo Bioworks Holdings, Inc. | 647.37M | -2.94% | 1,044,683 | 151.40M |
| 439 | FTH | Faeth Therapeutics, Inc. | 644.47M | 7.67% | 123,376 | - |
| 440 | AGMB | AgomAb Therapeutics NV | 639.24M | -27.16% | 264,159 | - |
| 441 | PHR | Phreesia, Inc. | 636.04M | - | 1,031,580 | 495.59M |
| 442 | MNPR | Monopar Therapeutics Inc. | 620.24M | -2.08% | 111,701 | - |
| 443 | RGNX | REGENXBIO Inc. | 619.34M | 1.27% | 1,617,252 | 87.82M |
| 444 | BWAY | BrainsWay Ltd. | 618.99M | 2.24% | 68,180 | 56.22M |
| 445 | PROK | ProKidney Corp. | 616.20M | 7.94% | 3,581,659 | 889.00K |
| 446 | CRMD | CorMedix Inc. | 615.85M | 2.75% | 1,359,891 | 400.05M |
| 447 | CTNM | Contineum Therapeutics, Inc. | 612.76M | 9.27% | 661,531 | - |
| 448 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 610.42M | -0.52% | 397,467 | - |
| 449 | EVH | Evolent Health, Inc. | 609.65M | -6.07% | 2,564,877 | 1.89B |
| 450 | NNNN | Anbio Biotechnology | 601.75M | 1.18% | 46,833 | 8.65M |
| 451 | GYRE | Gyre Therapeutics, Inc. | 601.23M | 2.02% | 61,487 | 117.05M |
| 452 | CBIO | Crescent Biopharma, Inc. | 598.12M | - | 267,188 | 11.88M |
| 453 | ALT | Altimmune, Inc. | 591.20M | 3.40% | 4,332,394 | 36.00K |
| 454 | CERS | Cerus Corporation | 585.08M | -2.34% | 2,174,285 | 216.56M |
| 455 | FLGT | Fulgent Genetics, Inc. | 582.78M | -0.05% | 251,706 | 320.35M |
| 456 | CTEV | Claritev Corporation | 581.50M | 0.86% | 179,927 | 978.76M |
| 457 | MDXG | MiMedx Group, Inc. | 573.44M | -1.53% | 1,187,826 | 389.42M |
| 458 | CTKB | Cytek Biosciences, Inc. | 572.10M | 2.07% | 1,178,948 | 204.17M |
| 459 | ZURA | Zura Bio Limited | 560.49M | 4.80% | 2,763,112 | - |
| 460 | STRO | Sutro Biopharma, Inc. | 550.14M | -0.45% | 344,487 | 99.61M |
| 461 | ASMB | Assembly Biosciences, Inc. | 544.78M | 1.97% | 249,382 | 71.10M |
| 462 | RZLT | Rezolute, Inc. | 543.23M | 1.96% | 3,367,927 | - |
| 463 | TOI | The Oncology Institute, Inc. | 542.91M | -3.04% | 2,160,241 | 545.76M |
| 464 | ANGO | AngioDynamics, Inc. | 542.28M | -1.59% | 164,661 | 313.73M |
| 465 | NPCE | NeuroPace, Inc. | 541.75M | -3.87% | 163,208 | 99.53M |
| 466 | KYTX | Kyverna Therapeutics, Inc. | 541.69M | 1.48% | 1,236,715 | - |
| 467 | MYGN | Myriad Genetics, Inc. | 539.30M | -2.39% | 1,599,204 | 829.00M |
| 468 | ARVN | Arvinas, Inc. | 536.17M | 0.24% | 519,322 | 89.40M |
| 469 | TLRY | Tilray Brands, Inc. | 535.58M | -2.60% | 3,753,404 | 858.28M |
| 470 | CLPT | ClearPoint Neuro, Inc. | 535.01M | -8.18% | 972,121 | 40.61M |
| 471 | XOMA | XOMA Royalty Corporation | 532.99M | 0.83% | 199,999 | 48.56M |
| 472 | STTK | Shattuck Labs, Inc. | 532.16M | 1.31% | 1,897,747 | 1.00M |
| 473 | PRLD | Prelude Therapeutics Incorporated | 528.62M | 8.11% | 829,415 | 16.72M |
| 474 | PRTA | Prothena Corporation plc | 521.96M | -1.81% | 339,626 | 57.94M |
| 475 | AQST | Aquestive Therapeutics, Inc. | 521.87M | - | 1,489,556 | 50.27M |
| 476 | PACB | Pacific Biosciences of California, Inc. | 521.81M | -2.89% | 6,885,072 | 160.03M |
| 477 | FBRX | Forte Biosciences, Inc. | 519.26M | -0.33% | 421,439 | - |
| 478 | SLN | Silence Therapeutics plc | 518.63M | 1.76% | 556,738 | 839.00K |
| 479 | OCGN | Ocugen, Inc. | 517.94M | -8.38% | 11,445,579 | 4.47M |
| 480 | CCCC | C4 Therapeutics, Inc. | 516.35M | 7.36% | 6,615,880 | 34.86M |
| 481 | CABA | Cabaletta Bio, Inc. | 507.10M | - | 4,570,536 | - |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 483 | OVID | Ovid Therapeutics Inc. | 502.06M | -1.10% | 2,970,544 | 7.12M |
| 484 | EDIT | Editas Medicine, Inc. | 497.22M | 1.25% | 1,844,477 | 38.69M |
| 485 | NGNE | Neurogene Inc. | 496.97M | -2.57% | 162,355 | 925.00K |
| 486 | KIDS | OrthoPediatrics Corp. | 491.35M | -4.73% | 242,927 | 243.30M |
| 487 | VALN | Valneva SE | 488.58M | 1.16% | 32,854 | 180.25M |
| 488 | NVCT | Nuvectis Pharma, Inc. | 487.80M | -35.54% | 3,139,680 | - |
| 489 | NRC | NRC Health | 485.22M | -0.51% | 116,767 | 138.64M |
| 490 | SOPH | SOPHiA GENETICS SA | 484.08M | -3.51% | 743,583 | 81.18M |
| 491 | EVMN | Evommune, Inc. | 478.68M | -11.69% | 1,756,917 | 10.00M |
| 492 | SGMT | Sagimet Biosciences Inc. | 477.34M | -0.77% | 900,935 | - |
| 493 | WEAV | Weave Communications, Inc. | 476.60M | -2.28% | 970,104 | 248.72M |
| 494 | ARTV | Artiva Biotherapeutics, Inc. | 471.31M | 1.25% | 490,002 | 251.00K |
| 495 | ANL | Adlai Nortye Ltd. | 470.00M | 2.98% | 188,461 | 5.00M |
| 496 | VTVT | vTv Therapeutics Inc. | 467.22M | 3.94% | 93,303 | 36.84M |
| 497 | BNTC | Benitec Biopharma Inc. | 459.66M | 5.35% | 66,770 | - |
| 498 | EOLS | Evolus, Inc. | 457.03M | -2.66% | 596,300 | 301.79M |
| 499 | SRTA | Strata Critical Medical, Inc. | 456.00M | 1.74% | 2,798,297 | 228.58M |
| 500 | CYH | Community Health Systems, Inc. | 452.41M | -1.47% | 1,443,773 | 12.29B |